Private equity firms are turning to minority transactions in increasing numbers, but landing a non-control deal requires a different approach to pursuing a buyout.
Nigel Kershaw, the chair of Big Issue Invest, reflects on how impact investing has grown from a financial oddity into a force transforming mainstream markets.
Catherine Lewis La Torre, the new head of British Patient Capital, lays out her vision for creating a homegrown venture ecosystem
The management team has become the crucial lever for value creation. Getting the most out of senior portfolio company executives, however, has become more complicated.
What 2019 holds for private equity: how dealmakers are preparing for an unpredictable year.
Private equity firms will hope a no-deal Brexit never happens, but GPs need to take steps to protect their interests.
Women are better represented in impact investing than private equity. But as impact goes mainstream its gender balance could be at risk
As Brexit approaches the relationship between the EIF and UK private equity faces an uncertain future.
The stakes are high in healthcare, but relentless demand still drives one of private equity’s most lucrative sectors.
With more and more deals being struck in the Internet of Things space, is it time for private equity to believe the hype?